疏血通注射液治疗急性脑梗死的临床分析

Efficacy of the Shuxuetong injection on acute cerebral infarction

目的:研究疏血通注射液治疗急性脑梗死的临床疗效。方法:纳入此次研究的80例急性脑梗死患者均为2017年1月-2018年4月期间收治,以随机分组法将其分为两组,一组为对照组给予常规治疗,一组为实验组给予疏血通注射液进行治疗,对比两组患者的治疗效果。结果:①两组患者在治疗前神经缺损功能评分没有差异,无统计学意义(P>0.05);治疗后实验组患者的神经缺损功能评分要明显优于对照组患者,数据差异具有统计学意义(P<0.05)。②实验组患者治疗总有效率95.0%明显高于对照组患者75.0%,数据差异具有统计学意义(P<0.05)。③两组患者红细胞比容、高切全血粘度、低切全血粘度、血浆黏度、红细胞电泳时间、纤维蛋白原、血小板聚集率指标变化比较,数据差异具有统计学意义(P<0.05)。结论:疏血通注射液治疗急性脑梗死的临床疗效较为理想,不仅降低了神经缺损功能评分,更改善了血液流变性,在临床治疗中有着广泛的应用前景。

Objective:To study efficacy of the Shuxuetong injection (疏血通注射液) on acute cerebral infarction.Methods: From January 2017 to April 2018,80 cases were divided into two groups.The control group was given conventional treatment;and the experimental group was given the Shuxuetong injection.Efficiency in two groups were compared.Results:Before treatment,there was no significant difference in the scores of neurological deficits between the two groups (P>0.05).After treatment,the neurological deficit function score in the experimental group was significantly better than the control group (P<0.05).The total efficiency in the experimental group was 95.0%,was significantly higher than 75.0% in the control group (P<0.05).There were significant differences in the changes of hematocrit,high-cut whole blood viscosity,low-cut whole blood viscosity,plasma viscosity,erythrocyte electrophoresis time,fibrinogen and platelet aggregation rate between the two groups (P<0.05).Conclusion:The Shuxuetong injection on acute cerebral infarction showed a good effect,can reduce neurological deficit function scores,and improve blood rheology.